Structural basis for translation inhibition by MERS-CoV Nsp1 reveals a conserved mechanism for betacoronaviruses.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
31 10 2023
Historique:
received: 16 06 2023
revised: 13 08 2023
accepted: 05 09 2023
medline: 6 11 2023
pubmed: 21 9 2023
entrez: 21 9 2023
Statut: ppublish

Résumé

All betacoronaviruses (β-CoVs) encode non-structural protein 1 (Nsp1), an essential pathogenicity factor that potently restricts host gene expression. Among the β-CoV family, MERS-CoV is the most distantly related member to SARS-CoV-2, and the mechanism for host translation inhibition by MERS-CoV Nsp1 remains controversial. Herein, we show that MERS-CoV Nsp1 directly interacts with the 40S ribosomal subunit. Using cryogenic electron microscopy (cryo-EM), we report a 2.6-Å structure of the MERS-CoV Nsp1 bound to the human 40S ribosomal subunit. The extensive interactions between C-terminal domain of MERS-CoV Nsp1 and the mRNA entry channel of the 40S ribosomal subunit are critical for its translation inhibition function. This mechanism of MERS-CoV Nsp1 is strikingly similar to SARS-CoV and SARS-CoV-2 Nsp1, despite modest sequence conservation. Our results reveal that the mechanism of host translation inhibition is conserved across β-CoVs and highlight a potential therapeutic target for the development of antivirals that broadly restrict β-CoVs.

Identifiants

pubmed: 37733586
pii: S2211-1247(23)01168-3
doi: 10.1016/j.celrep.2023.113156
pii:
doi:

Substances chimiques

RNA, Messenger 0
Viral Nonstructural Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

113156

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM132358
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests Y.X. serves on the advisory board of Cell Reports.

Auteurs

Swapnil C Devarkar (SC)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.

Michael Vetick (M)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.

Shravani Balaji (S)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.

Ivan B Lomakin (IB)

Department of Dermatology, Yale University School of Medicine, New Haven, CT 06520, USA.

Luojia Yang (L)

Systems Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.

Danni Jin (D)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.

Wendy V Gilbert (WV)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.

Sidi Chen (S)

Systems Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.

Yong Xiong (Y)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA. Electronic address: yong.xiong@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH